Vitarka Therapeutics
PrivateLast Round
Grant
Jun 1, 2023
Total Funding Raised
$2.92M
Company Overview
Vitarka Therapeutics is a biotechnology company developing a targeted non-viral delivery platform designed for intracellular targets in neuroscience and neurodegeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vitarka Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Vitarka Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2023 | ||||
| Seed | Apr 6, 2023 | ||||
| Grant | Mar 1, 2023 | ||||
| Grant | Nov 1, 2022 | ||||
| Seed | May 9, 2022 |
Vitarka Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed, Grant |
| IndieBio | Accelerator |
| UK Innovation & Science Seed Fund | Seed |
| SOSV | Seed, Accelerator |
| Discovery Park Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2024
Monthly visitors increased 676% MoM.
- Jun 1, 2023
$540K raised in grant funding.
Vitarka Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vitarka Therapeutics's valuation, stock price, and market status.
